Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?

Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?

Item
http://www.wikidata.org/entity/Q38340865
A blue fluorescent labeling technique utilizing micro- and nanoparticles for tracking in LIVE/DEAD® stained pathogenic biofilms of Staphylococcus aureus and Burkholderia cepaciaA Novel Computerized Cell Count Algorithm for Biofilm Analysis.The History of Therapeutic Aerosols: A Chronological Review.The long and winding road to inhaled TB therapy: not only the bug's fault.Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.Drug delivery to the lungs: challenges and opportunities.Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity
P2860

Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?

Item
http://www.wikidata.org/entity/Q38340865
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Aspects of pulmonary drug deli ...... c fibrosis--where do we stand?
@en
type
label
Aspects of pulmonary drug deli ...... c fibrosis--where do we stand?
@en
prefLabel
Aspects of pulmonary drug deli ...... c fibrosis--where do we stand?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Aspects of pulmonary drug deli ...... c fibrosis--where do we stand?
@en
P2093
P2860
P304
P31
P356
10.1517/17425247.2015.1007949
P407
P433
P478
P50
P577
P5875
P698
P921